NASDAQ$BTTC

Black Titan Corp · Q1 2012 earnings

Q1 2012 earnings · · Investor relations

Headline financials

Total Revenue

$1.27M

Previous: $948K+34.0%
EPS (adj)

-$2.70

Previous: -$75.39+96.4%
Capital Expenditures

$522K

No prior period
Free Cash Flow

-$3.05M

No prior period
Net Income

-$5.16M

Previous: -$4.51M-14.4%
Operating Income

-$3.53M

Previous: -$3.58M+1.4%
Gross Profit

$1.27M

Previous: $948K+34.0%
Cash & Equivalents

$2.31M

No prior period
Total Assets

$7.51M

No prior period
Stock-Based Comp

$1.55M

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$1.27M

Q1 2012+34%vs Q1 2011
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro